Abstract
A series of previous studies have indicated that the NC16a domain of the 180-kDa bullous pemphigoid antigen (BP180) is the most immunogenic and probably pathogenic region in both bullous pemphigoid and herpes gestationis. To confirm these previous results by a large-scale study, we examined serum from 154 bullous pemphigoid and 43 herpes gestationis patients using an immunoblot technique with the BP180 NC16a domain fusion protein, which had been prepared using cDNA obtained from a human keratinocyte cDNA library by polymerase chain reaction amplification. This fusion protein was recognized by 90% of bullous pemphigoid and 79% of herpes gestationis serum samples, but not by any other disease or normal control serum samples. These results indicate that this system is very sensitive and specific for the detection of anti-BP180 antibodies and should be useful for the diagnosis of various subepidermal bullous diseases.
Similar content being viewed by others
References
Stanley JR (1989) Pemphigus and pemphigoid as paradigm of organ-specific, autoantibody-mediated diseases. J Clin Invest 83:1443–1448
Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI (1981) Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 24:897–903
Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA (1986) Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 136:1231–1235
Sugi T, Hashimoto T, Hibi T, Nishikawa T (1989) Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them. J Clin Invest 84: 1050–1055
Ebihara T, Hashimoto T, Kudoh J, Gamou S, Shimizu N, Nishikawa T (1993) Detection of the 170-kDa bullous pemphigoid antigen by immunoprecipitation. J Invest Dermatol 100: 176–179
Morrison LH, Labib RS, Zone JJ, Diaz LA, Anhalt GJ (1988) Herpes gestations autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest 87:2023–2026
Tanaka T, Parry DAD, Klaus-Kovtun V, Steinert PM, Stanley JR (1991) Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins. J Biol Chem 266:12555–12559
Sawamura D, Li K, Chu ML, Uitto J (1991) Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains. J Biol Chem 266:17784–17790
Diaz LA, Ratrie H III, Saunders WS, Futamura S, Squiquera HL, Anhalt GJ, Giudice GJ (1990) Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis. J Clin Invest 86:1088–1094
Giudice GJ, Emery DJ, Diaz LA (1992) Cloning and primary structural analysis of the bullous pemphigoid autoantigen, BP-180. J Invest Dermatol 99:243–250
Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Diaz LA (1993) Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 151:5742–5750
Giudice GJ, Wilske KC, Anhalt GJ, Fairley JA, Taylor AF, Emery DJ, Hoffman RG, Diaz LA (1994) Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol 102:878–881
Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA Giudice GJ (1993) A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92:2480–2488
Amagai M, Klaus-Kovtun V, Stanley JR (1991) Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869–877
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsumura, K., Amagai, M., Nishikawa, T. et al. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res 288, 507–509 (1996). https://doi.org/10.1007/BF02505245
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02505245